Neoprobe Corporation (AMEX: NEOP)


Date: 
Tue, 03/29/2011

3/29/2011, we released our published research report, "TooNiceStocks Initiates Coverage on Neoprobe Corporation (AMEX: NEOP) - Researching the Near Term Catalyst, Fundamental and Product Pipeline".  Our members were notified @ $2.48 and ran to $4.25 rallying up to 71.37%.  In February, NEOP had a meeting with the U.S. Food and Drug Administration re-initiated the development for the RIGScan CR technology for detection of colorectal cancer tumors. Please read our original report here.



Join our Free Newsletter!